ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
June 19, 2011  |  By ENCOD In 2011

WHY WE NEED TO TAKE MAGIC MUSHROOMS SERIOUSLY

arton3171

Source: Good Health

June 18 2011


Psilocybin. It’s the psychoactive substance in those “sacred mushrooms” that causes hallucinations and other novel mental experiences. The effects of those mushrooms have been explored and appreciated by members of the ancient Capsian culture in North Africa, Aztec shamans, and modern college students. But they’re now the subject of serious study by scientists.

A team from the Johns Hopkins University School of Medicine recently published results from a roughly year-long experiment. The researchers worked with 18 volunteers who were given pure psilocybin to measure how it affected people and how different dosages changed the experience. The subjects were screened for psychological health and given the drug in a pleasant environment, after preparatory guidance. They even had a soundtrack consisting of “classical and world music chosen to complement the arc of the psilocybin action, from onset, through the peak of the effects, and subsiding back to baseline.”

The results? At high dosages people occasionally experienced fear, anxiety, or delusions. But the negative effects of those “bad trips” were easily mitigated by the reassuring researchers and didn’t outlast the session. At more moderate doses, the results were almost unambiguously positive. Moreover, people didn’t just appreciate the experience as fun; they found it spiritually meaningful, with lasting benefits.

As a piece on Newswise explains:

Looking back over a year later, most of the experiment’s 18 volunteers (94 percent) rated a psilocybin session as among the top five most or as the topmost spiritually significant experience of his or her life. […] Most volunteers (89 percent) also reported positive changes in their behaviors, and those reports were corroborated by family members or others, the researchers say. The behavior changes most frequently cited were improved relationships with family and others, increased physical and psychological self-care, and increased devotion to spiritual practice.

Reading the volunteers’ first-hand reports of how the experiences affected them is a testament to their value. “More and more, sensuality and compassion and gratitude continue to unfold around me.” “I try to judge less and forgive more.” “I feel that I relate better in my marriage. There is more empathy.” “I need less food to make me full. My alcohol use has diminished dramatically.”

I’m not saying we should all start doing mushrooms. These were carefully measured doses, taken in a setting designed to be comfortable and supportive. There are certainly situations in which it would be dangerous or irresponsible to take psilocybin.

But these results illustrate the artificial dichotomy between medicine and recreational drugs in America. Stateside, Prozac is regarded as medicine, but psilocybin is a schedule 1 controlled substance like heroin. Americans assume that if some substance is made by nature instead of Eli Lilly, it can’t be medicine. But if psilocybin has true psychiatric and emotional benefits, what’s the difference? Sure, you can have a bad experience with psilocibin, but antidepressents like Prozac have been linked to suicidal thoughts, and it’s hard to imagine a worse side effect than that. We also think that if a drug is used for fun, there must be something bad about it. But Vicodin and OxyContin are all still on the market. There are plenty of FDA-approved drugs that get used (and abused) recreationally.

We should aim to evaluate any drug objectively, whether it’s made by an enormous pharmaceutical company or grows in the forest. If an engineered antidepressant generated reports like those from the volunteers in this study, it would be regarded as a breakthrough in psychiatric medicine.

Previous StoryFERIA DE LA COCA Y SUS DERIVADOS EN BOLIVIA, A REALIZARSE 18 – 19 DE JUNIO
Next StoryTHE HIGH PRICE OF PROHIBITION

Related Articles

  • THE TOP TEN INTERNATIONAL DRUG POLICY STORIES OF 2011
  • arton3477
    HOW THE PENTAGON WILL PRIVATIZE THE WAR ON DRUGS

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
WHY WE NEED TO TAKE MAGIC MUSHROOMS SERIOUSLY